These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 28110473)

  • 21. Self-Report and Dry Blood Spot Measurement of Antiretroviral Medications as Markers of Adherence in Pregnant Women in Rural South Africa.
    Alcaide ML; Ramlagan S; Rodriguez VJ; Cook R; Peltzer K; Weiss SM; Sifunda S; Jones DL
    AIDS Behav; 2017 Jul; 21(7):2135-2140. PubMed ID: 28361454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protocol for an open-label, single-arm trial of HIV pre-exposure prophylaxis (PrEP) among people at high risk of HIV infection: the NSW Demonstration Project PRELUDE.
    Vaccher S; Grulich A; McAllister J; Templeton DJ; Bloch M; McNulty A; Holden J; Poynten IM; Prestage G; Zablotska I;
    BMJ Open; 2016 Jun; 6(6):e012179. PubMed ID: 27324719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Markers of poor adherence among adults with HIV attending Themba Lethu HIV Clinic, Helen Joseph Hospital, Johannesburg, South Africa.
    Nnambalirwa M; Govathson C; Evans D; McNamara L; Maskew M; Nyasulu P
    Trans R Soc Trop Med Hyg; 2016 Dec; 110(12):696-704. PubMed ID: 28938050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perceptions and Experiences with the VOICE Adherence Strengthening Program (VASP) in the MTN-003 Trial.
    van der Straten A; Mayo A; Brown ER; Amico KR; Cheng H; Laborde N; Marrazzo J; Torjesen K
    AIDS Behav; 2015 May; 19(5):770-83. PubMed ID: 25384907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adherence and the Lie in a HIV Prevention Clinical Trial.
    Stadler J; Scorgie F; van der Straten A; Saethre E
    Med Anthropol; 2016; 35(6):503-516. PubMed ID: 26575611
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Barriers to antiretroviral adherence in HIV-positive patients receiving free medication in Kayunga, Uganda.
    Senkomago V; Guwatudde D; Breda M; Khoshnood K
    AIDS Care; 2011 Oct; 23(10):1246-53. PubMed ID: 21939403
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experiences of HIV-positive postpartum women and health workers involved with community-based antiretroviral therapy adherence clubs in Cape Town, South Africa.
    Trafford Z; Gomba Y; Colvin CJ; Iyun VO; Phillips TK; Brittain K; Myer L; Abrams EJ; Zerbe A
    BMC Public Health; 2018 Jul; 18(1):935. PubMed ID: 30064405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation.
    Liu AY; Hessol NA; Vittinghoff E; Amico KR; Kroboth E; Fuchs J; Irvin R; Sineath RC; Sanchez T; Sullivan PS; Buchbinder SP
    AIDS Patient Care STDS; 2014 Dec; 28(12):622-7. PubMed ID: 25396706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of adherence measures of antiretroviral prophylaxis in HIV exposed infants in the first 6 weeks of life.
    Desmond AC; Moodley D; Conolly CA; Castel SA; Coovadia HM
    BMC Pediatr; 2015 Mar; 15():23. PubMed ID: 25885678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pre-exposure Prophylaxis Adherence Measured by Plasma Drug Level in MTN-001: Comparison Between Vaginal Gel and Oral Tablets in Two Geographic Regions.
    Minnis AM; van der Straten A; Salee P; Hendrix CW
    AIDS Behav; 2016 Jul; 20(7):1541-8. PubMed ID: 25969178
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors affecting adherence to antiretroviral therapy among pregnant women in the Eastern Cape, South Africa.
    Adeniyi OV; Ajayi AI; Ter Goon D; Owolabi EO; Eboh A; Lambert J
    BMC Infect Dis; 2018 Apr; 18(1):175. PubMed ID: 29653510
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pilot evaluation of a second-generation electronic pill box for adherence to Bedaquiline and antiretroviral therapy in drug-resistant TB/HIV co-infected patients in KwaZulu-Natal, South Africa.
    Bionghi N; Daftary A; Maharaj B; Msibi Z; Amico KR; Friedland G; Orrell C; Padayatchi N; O'Donnell MR
    BMC Infect Dis; 2018 Apr; 18(1):171. PubMed ID: 29642874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial.
    Bekker LG; Roux S; Sebastien E; Yola N; Amico KR; Hughes JP; Marzinke MA; Hendrix CW; Anderson PL; Elharrar V; Stirratt M; Rooney JF; Piwowar-Manning E; Eshleman SH; McKinstry L; Li M; Dye BJ; Grant RM;
    Lancet HIV; 2018 Feb; 5(2):e68-e78. PubMed ID: 28986029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementation of Option B and a fixed-dose combination antiretroviral regimen for prevention of mother-to-child transmission of HIV in South Africa: A model of uptake and adherence to care.
    Maskew M; Jamieson L; Mohomi G; Long L; Mongwenyana C; Nyoni C; Mokaba D; Fox MP; Sanne I; Rosen S
    PLoS One; 2018; 13(8):e0201955. PubMed ID: 30161147
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Negotiating the use of female-initiated HIV prevention methods in a context of gender-based violence: the narrative of rape.
    Hartmann M; Montgomery E; Stadler J; Laborde N; Magazi B; Mathebula F; van der Straten A
    Cult Health Sex; 2016; 18(6):611-24. PubMed ID: 26551920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. "It Was Not My Aim to Sleep There": The Impact of Timing and Location of Sex on Adherence to Coitally-Dependent HIV Pre-exposure Prophylaxis.
    Scorgie F; Stadler J; Baron D; Ju S; Ikaneng T; Mabude Z; Makgopa S; Malefo MA; Manenzhe KN; Mazibuko T; Ntjana H; Nkala B; Palanee-Phillips T; Gray G; Rees H; Delany-Moretlwe S
    AIDS Behav; 2018 Nov; 22(11):3692-3704. PubMed ID: 29909589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A qualitative study of obstacles to diaphragm and condom use in an HIV prevention trial in sub-Saharan Africa.
    Kacanek D; Dennis A; Sahin-Hodoglugil NN; Montgomery ET; Morar N; Mtetwa S; Nkala B; Phillip J; Watadzaushe C; van der Straten A;
    AIDS Educ Prev; 2012 Feb; 24(1):54-67. PubMed ID: 22339145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A systematic review of adherence to oral pre-exposure prophylaxis for HIV - how can we improve uptake and adherence?
    Sidebottom D; Ekström AM; Strömdahl S
    BMC Infect Dis; 2018 Nov; 18(1):581. PubMed ID: 30445925
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Factors associated with short-course antiretroviral prophylaxis (dual therapy) adherence for PMTCT in Nkangala district, South Africa.
    Peltzer K; Sikwane E; Majaja M
    Acta Paediatr; 2011 Sep; 100(9):1253-7. PubMed ID: 21366691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estimating efficacy in a randomized trial with product nonadherence: application of multiple methods to a trial of preexposure prophylaxis for HIV prevention.
    Murnane PM; Brown ER; Donnell D; Coley RY; Mugo N; Mujugira A; Celum C; Baeten JM;
    Am J Epidemiol; 2015 Nov; 182(10):848-56. PubMed ID: 26487343
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.